The advantages of dual nationality

Lewison, Grant
May 1991
New Scientist;5/4/91, Vol. 130 Issue 1767, p50
Comments on the preponderance of transnational authorship in papers resulting from the first biotechnology program (BEP) at the University of Manchester. The European Commission as one of the most importance science funding bodies in the world; The Programme for Policy Research in Engineering, Science and Technology (PREST); More.


Related Articles

  • Launch of food allergy study welcomed.  // Food & Drink Technology;Apr2013, Vol. 12 Issue 7, p8 

    The article focuses on the international study titled "Integrated Approaches to Food Allergen and Allergy Risk Management (iFAAM)," associated with the food allergy, led by the University of Manchester, Manchester, England and financed by European Commission has been launched in Great Britain.

  • Barcelona EC Biotech Initiative.  // Life Science Today;Apr/May2002, Vol. 3 Issue 2, p8 

    Reports the policy initiative of the European Commission for the development of life sciences and biotechnology in Europe.

  • Biotech or Bust. Gopal, Kevin // Pharmaceutical Executive;Mar2002, Vol. 22 Issue 3, p30 

    Reports the move of the European Commission in promoting biotechnology in Brussels, Belgium. Implementation of biotechnology strategies; Economic objectives of the European Union; Establishment of risk capital sources for biotechnology.

  • Ethical aspects of the labelling of foods derived from modern biotechnology.  // Politics & the Life Sciences;Mar96, Vol. 15 Issue 1, p117 

    Presents opinions from The Group of Advisers to the European Commission on the ethical aspects of the labelling of foods derived from modern biotechnology.

  • European biotechnology governance seizes up. Hodgson, John // Nature Biotechnology;May99, Vol. 17 Issue 5, p418 

    Reports on the effect of no governance in the European Union on European biotechnology. Impact of the delay in the election of governance on revisions to existing legislation on genetically modified organisms; Measure that is likely to be affected by European governmental vacuum; Influence of...

  • A matter of life and death. Grace, Maggie // New Scientist;7/27/96, Vol. 151 Issue 2040, p60 

    Focuses on the controversy generated by the issues related to the European Commission's policies regarding biotechnological patents. Negotiations between the Commission and the European Parliament for a directive on the legal protection of biotechnological inventions; Patent on an invention...

  • ...but parliament wants closer scrutiny. A.A. // Nature;7/24/1997, Vol. 388 Issue 6640, p314 

    Considers the concerns of the European Parliament on the debate on bioethics in Europe. The concern about the effects of biotechnological research on society; Amendments to the European Commission's draft directive on the legal protection of biotechnological inventions.

  • SusChem makes strides. O'Driscoll, Cath // European Chemical News;11/14/2005, Vol. 83 Issue 2171, p20 

    This article reports on the expected endorsement of the core strategic research agenda (SRA) of SusChem, the Cefic/EuropaBio technology platform for sustainable chemistry at a meeting in London, England in December 2005. SusChem was set up at the prompting of the European Commission and aims to...

  • BIOTECHNOLOGY. Scott, Alex // Chemical Week;2/6/2002, Vol. 164 Issue 5, p15 

    Focuses on the policy initiatives created by the European Commission to support the European Union biotechnology sector. Components of the initiatives; Comment from Romano Prodi, president of the Commission, on the importance of the ethical code of practice.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics